BrdU anticorps

N° du produit ABIN7112073

Détail du produit anti-BrdU anticorps

Antigène: BrdU (Bromodeoxyuridine (BrdU))

Reactivité: Humain, Souris, Rat

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp BrdU est non-conjugé

Application: Immunohistochemistry (IHC), Immunofluorescence (IF), ELISA

Purification: Protein A+G purification

Pureté: ≥95 % as determined by SDS-PAGE

Immunogène: compound

Clone: 9E8

Isotype: IgG2a

Information d'application

Indications d'application: IHC: 1:200-1:1000, IF: 1:50-1:500

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: -20°C for 12 months (Avoid repeated freeze / thaw cycles.)

Date de péremption: 12 months

Détails sur BrdU

Antigène: BrdU (Bromodeoxyuridine (BrdU))

Autre désignation: BrdU (BrdU Produits)

Classe de substances: Chemical

Sujet: Synonyms:5-bromo-2-deoxyuridine, BrDu, BrdUrd, Bromodeoxyuridine, BUdR Background:Bromodeoxyuridine(5-bromo-2'-deoxyuridine, BrdU, BUdR, BrdUrd) is a synthetic nucleoside that is an analog of thymidine. It can be incorporated into the newly synthesized DNA of replicating cells(during the S phase of the cell cycle), substituting for thymidine during DNA replication. As such, BrdU is used for birth dating and monitoring cell proliferation. BrdU is a toxic and mutagenic substance. It triggers cell death, the formation of teratomas, alters DNA stability, lengthens the cell cycle, and has mitogenic, transcriptional and translational effects on cells that incorporate it. This antibody does not cross react with Thymidine.